Virginia · House Bill 2106 · 2025 Regular Session

Health insurance; prohibits pharmacy override for enrollee with sickle cell disease.

  1. Introduced Jan 7, 2025
  2. In committee Jan 7, 2025
  3. Died  
  4. Passed the Senate  
  5. To the governor  
  6. Became law  

What it does

The legislature's own summary of the bill, or its official long title.

Health insurance; pharmacy override for enrollee with sickle cell disease; prohibited. Prohibits a health insurance carrier from requiring a pharmacy to override a denial code or to request an override in order to dispense a prescription drug for the treatment or management of pain to an enrollee who has been diagnosed with sickle cell disease.

Every action

6 steps, oldest first, as the legislature records them.

  1. House of DelegatesPrefiled and ordered printed; Offered 01-13-2025 25101618D
  2. CommitteeReferred to Committee on Labor and Commerce · House of Delegates Labor and Commerce
  3. CommitteeAssigned L & C sub: Subcommittee #1 · House of Delegates Labor and Commerce: Subcommittee 1
  4. CommitteePlaced on Labor and Commerce Agenda · House of Delegates Labor and Commerce
  5. CommitteeSubcommittee recommends laying on the table (4-Y 3-N) · House of Delegates Labor and Commerce: Subcommittee 14–3 vote
  6. CommitteeLeft in Labor and Commerce · House of Delegates Labor and Commerce

Roll calls

1 recorded vote: 0 on the floor, 1 in committee. Each shows how every member voted.

Committee votes

DateWhereQuestionResult
Jan 21, 2025 House of Delegates Labor and Commerce: Subcommittee 1 Subcommittee recommends laying on the table (4-Y 3-N)
Members

Yes · 4

No · 3

Not voting · 1

4–3

Sponsors

The member who introduced it.

From Virginia's official records (lis.blob.core.windows.net), checked Nov 13, 2026. Text links go to the official versions; LegiList does not copy bill text.